Nautilus emerges with $76M to become the ‘Illumina of proteomics’
Seattle headquartered, Nautilus Biotechnology announced a $76 million series B round to fund its work analyzing and quantifying the human proteome.
Nautilus Biotechnology is looking to study proteins in a similar way to what Illumina did for genomics.
PHOTO: Nautilus Biotechnology’s founders are Sujal Patel (pictured) and Parag Mallick. (Image courtesy Nautilus Biotechnology)